Zimbabwe has rejected a significant US healthcare agreement valued at $367m (272 million pounds) spanning five years due to Washington's request for confidential data.
The decision was revealed following a government memo from December was leaked, revealing that President Emmerson Mnangagwa believed the deal was "unbalanced".
An official spokesman later clarified that the United States was seeking genetic material for research and commercial purposes while was unwilling to guarantee the benefits from any future vaccines.
"We will now turn to the challenging and unfortunate task of ending our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had donated over $1.9bn for health programmes to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for further negotiations to find a agreement acceptable to both sides so the nation's critical HIV programme can be sustained.
Wider Context
This development follows a similar case in Kenya, where a court suspended a related health funding agreement following concerns were raised about the security of Kenyans' health data.
Since returning to the presidency recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
USAID had managed aid for the US government, but Trump argued its spending was "inefficient" and his administration was seeking government-to-government deals to boost openness and responsibility.
Based on reports, Sixteen African countries have so far signed similar health pacts, representing more than $18.3bn in committed funds.
Details of the Declined Agreement
This assistance for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this cooperation would have delivered significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving antiretroviral therapy via American-funded initiatives," the Ambassador added.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"Our nation was requested to share its genetic material and health information for a long time, without any equivalent guarantee of access to any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that shared data," Mangwana explained.
"In essence, our country would provide the basic resources for scientific discovery with no certainty that the resulting innovations would be available to our citizens if a future health crisis emerge."
National Interest and Global Health
Mangwana further said that the American exit from the global health body and its pursuit of bilateral deals were undermining systems previously established through the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with potential global health emergencies.
"This framework is intended to ensure that when a country contributes its samples, the resulting advantages – including medicines and cures – are shared equitably, not monopolised solely by those with the capability to create them."
Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We encourage further dialogue with our US partners on how future co-operation could be arranged in a way that honours the sovereignty and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but recommended that negotiations should continue since a large portion of the nation's Aids initiatives were funded by international support.
"Where technical issues exist, such as those involving information security or agreement terms, these can frequently be resolved via technical clarification and mutually agreed protections," it added.
The halted deal emphasises the continuing challenges between receiving vital international aid and safeguarding a country's data in an increasingly data-driven world.